Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persistersKei Kunimasa, Yoshihiro Nishimura|Cancer Science|2017Cited by 37
Interaction between Immunotherapy and Antiangiogenic Therapy for CancerKoichi Furukawa, Yoshihiro Nishimura|Molecules|2020Cited by 35
Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cellsKanoko Umezawa, Yoshihiro Nishimura|Respiratory Research|2019Cited by 14
Amphiregulin as a Novel Resistance Factor for Amrubicin in Lung Cancer CellsS. Tokunaga, Yoshihiro Nishimura|Anticancer Research|2017Cited by 8
<p>Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma</p>Nanako Miwa, Yoshihiro Nishimura|OncoTargets and Therapy|2020Cited by 4